2011Journal of Baotou Medical CollegeRequires access

Inhibition Effects of Anti-cancer Bioactive Peptide on Hepatocarcinoma H_(22) Tumor-bearing Mice

SU Xiu-lan

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of anti-cancer bioactive peptide(ACBP) on hepatocarcinoma H22 tumor-bearing mice,and to elucidate the possible mechanisms of inhibition.Methods: Animal model of hepatocarcinoma H22 tumor-bearing mice were established.And the mice were randomly divided into three groups,and were treated with 5-Fu,ACBP,physiological saline by caudal vein injection,respectively.The mice were fed 10 days and were treated every other day.Then the mice were executed,inhibitory rate(IR) and spleen index(SI) were calculated.Cell cycle and apoptosis were detected by flow cytometry.Results: Tumor growth was inhibited by ACBP.The IR was 54.20%.Cell cycle was stopped at the G0/G1 phase and apoptosis was induced by ACBP.Conclusion: ACBP could inhibit DNA synthesis of liver cancer cells and induce apoptosis.

About this research paper

What this paper is about

Objective:To investigate the effects of anti-cancer bioactive peptide(ACBP) on hepatocarcinoma H22 tumor-bearing mice,and to elucidate the possible mechanisms of inhibition.Methods: Animal model of hepatocarcinoma H22 tumor-bearing mice were established.And the mice were randomly divided into three groups,and were treated with 5-Fu,ACBP,physiological saline by caudal vein injection,respectively.The mice were fed 10 days and were treated every other day.Then the mice were executed,inhibitory rate(IR) and spleen index(SI) were calculated.Cell cycle and apoptosis were detected by flow cytometry.Results: Tumor growth was inhibited by ACBP.The IR was 54.20%.Cell cycle was stopped at the G0/G1 phase and apoptosis was induced by ACBP.Conclusion: ACBP could inhibit DNA synthesis of liver cancer cells and induce apoptosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of anti-cancer bioactive peptide(ACBP) on hepatocarcinoma H22 tumor-bearing mice,and to elucidate the possible mechanisms of inhibition.Methods: Animal model of hepatocarcinoma H22 tumor-bearing mice were established.And the mice were randomly divided into three groups,and were treated with 5-Fu,ACBP,physiological saline by caudal vein injection,respectively.The mice were fed 10 days and were treated every other day.Then the mice were executed,inhibitory rate(IR) and spleen index(SI) were calculated.Cell cycle and apoptosis were detected by flow cytometry.Results: Tumor growth was inhibited by ACBP.The IR was 54.20%.Cell cycle was stopped at the G0/G1 phase and apoptosis was induced by ACBP.Conclusion: ACBP could inhibit DNA synthesis of liver cancer cells and induce apoptosis.

Key concepts: Apoptosis, Cell cycle, Flow cytometry, Spleen, Cancer, Chemistry, Cancer research, Cancer cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibition Effects of Anti-cancer Bioactive Peptide on Hepatocarcinoma H_(22) Tumor-bearing Mice — Research Paper | ScholarLens